Mohamed H. Aswad

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.

JAK2V617F mutation and circulating extracellular vesicles in essential thrombocythemia.

Journal: Clinical hemorheology and microcirculation

Published: June 19, 2023

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.

Journal: Neoplasma

Published: July 29, 2021

The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.

The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.

Journal: In vivo (Athens, Greece)

Published: June 14, 2021

High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.

High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: April 19, 2019

Showing 1-4 of 4

Last Updated: 09/26/2026